Sunday, 27 November 2022

 

 

LATEST NEWS ‘Red Shoes’ deals with gender-based violence against women in Mexico The Storyteller directed by Ananth Mahadevan premieres in the ‘Divyangjan’ section of 53rd IFFI Want viewers to be part of my cinematic universe: Filipino Director Lav Diaz ‘Ayushmaan’ – A real life story on the greatest journey of hope eGramSwaraj and Audit Online of Ministry of Panchayati Raj wins GOLD AWARD under the National Awards for e-Governance Department of Animal Husbandry inaugurates Animal Quarantine Certification Services in Bengaluru Ministry of Culture organises State level final competition for Delhi under Vande Bharatam at India Gate today Narendra Modi addresses Constitution Day celebrations in the Supreme Court of India President of India Graces The Valedictory Function of The Constitution Day Celebrations Organised by The Supreme Court of India Synergic functioning of Legislature, Judiciary and Executive is vital for democracy : Jagdeep Dhankhar Blood Donation Camp By NCC Units Of NCC Group Srinagar Operation of brain tumor in Civil Hospital, Ambala, no one can imagine how big it is : Anil Vij Vigilance Bureau Arrests Assistant Field Officer Markfed For Demanding Bribe Rs 52,000 Mental health and well being prime concern of modern society: R.D. Dhiman Watch today the World Television Premiere of Neeru Bajwa and Rubina Bajwa starrer Beautiful Billo at 1 p.m. on Zee Punjabi More Than 21000 Jobs In Merely Eight Months Reflects Commitment Of State Government For Welfare Of Youth: Bhagwant Mann Advocate General office celebrates Constitution Day Giant strides are being taken in the field of IT and new age technologies for better delivery of governance to citizens: Dr Jitendra Singh Maruti Suzuki & LPU Collaborated to host EFFICYCLE-2022 Competition at LPU Campus Chief Secretary R.D. Dhiman chairs high level meeting to review winter preparedness District-Level Constitution Day Function Held At Bachat Bhawan

 

This antiviral drug blocks Covid virus within 24 hrs: Study

Web Admin

Web Admin

5 Dariya News

New York , 05 Dec 2020

Researchers have discovered that the treatment of SARS-CoV-2 infection (Covid-19) with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses the virus transmission within 24 hours.According to the study, published in the journal Nature Microbiology, the research team from Georgia State University (GSU) originally discovered that the drug is potent against influenza viruses."This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission. MK-4482/EIDD-2801 could be game-changing," said study author Richard Plemper from GSU.Because the drug can be taken by mouth, treatment can be started early for a potentially three-fold benefit: inhibit patients' progress to severe disease, shorten the infectious phase to ease the emotional and socio-economic toll of prolonged patient isolation and rapidly silence local outbreaks,"We noted early on that MK-4482/EIDD-2801 has broad-spectrum activity against respiratory RNA viruses and that treating infected animals by mouth with the drug lowers the amount of shed viral particles by several orders of magnitude, dramatically reducing transmission," said Plemper."These properties made MK-4482/EIDD/2801 a powerful candidate for pharmacologic control of Covid-19," Plemper added.In the study, the research team repurposed MK-4482/EIDD-2801 against SARS-CoV-2 and used a ferret model to test the effect of the drug on halting virus spread.The team believe ferrets are a relevant transmission model because they readily spread SARS-CoV-2, but mostly do not develop severe disease, which closely resembles SARS-CoV-2 spread in young adults.The researchers infected ferrets with SARS-CoV-2 and initiated treatment with MK-4482/EIDD-2801 when the animals started to shed virus from the nose."When we co-housed those infected and then treated source animals with untreated contact ferrets in the same cage, none of the contacts became infected," said study co-author Josef Wolf.If these ferret-based data translate to humans, Covid-19 patients treated with the drug could become non-infectious within 24 hours after the beginning of treatment."MK-4482/EIDD-2801 is in advanced phase II/III clinical trials against SARS-CoV-2 infection," the authors wrote.

 

Tags: Health , Study , New York , Research , Researchers , World News , Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , COVAXIN , COVISHIELD , Covid-19 Vaccine , Covid-19 Vaccine in India

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD